Arbeitspapier

Biofármacos no Brasil: Características, importância e delineamento de políticas públicas para seu desenvolvimento

The text discusses possibilities of public policies for the development of biopharmaceuticals in Brazil, with emphasis on monoclonal antibodies (mAbs). First section discusses the basic concepts about biotechnology, biopharmaceuticals and monoclonal antibodies in order to sustain the later development of the work. Next, it discusses the evolution of the global pharmaceutical industry, emphasizing biopharmaceuticals, its value chain and general industry challenges. Then, it discusses the Brazilian scenario, emphasizing industry structure, demand, mainly of SUS (Brazilian Health System), regulation and actors involved in the chain or value network. Finalizing the text, a discussion on possibilities and alternatives for the development of public policies that help to leverage the development of this relevant industry.

Sprache
Portugiesisch

Erschienen in
Series: Texto para Discussão ; No. 2398

Klassifikation
Wirtschaft
Technological Change: Government Policy
Chemicals; Rubber; Drugs; Biotechnology; Plastics
Thema
biopharmaceuticals
drug innovation
public policy

Ereignis
Geistige Schöpfung
(wer)
Salerno, Mario Sergio
Matsumoto, Cristiane
Ferraz, Isabela
Ereignis
Veröffentlichung
(wer)
Instituto de Pesquisa Econômica Aplicada (IPEA)
(wo)
Brasília
(wann)
2018

Handle
Letzte Aktualisierung
10.03.2025, 11:44 MEZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
ZBW - Deutsche Zentralbibliothek für Wirtschaftswissenschaften - Leibniz-Informationszentrum Wirtschaft. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Objekttyp

  • Arbeitspapier

Beteiligte

  • Salerno, Mario Sergio
  • Matsumoto, Cristiane
  • Ferraz, Isabela
  • Instituto de Pesquisa Econômica Aplicada (IPEA)

Entstanden

  • 2018

Ähnliche Objekte (12)